X4 Pharmaceuticals, Inc. buy HC Wainwright
Start price
28.06.24
/
50%
€0.60
Target price
28.06.25
€4.67
Performance (%)
-10.57%
Price
08.07.24
€0.54
Summary
This prediction is currently active. The prediction for X4 Pharmaceuticals, Inc. disappoints with a performance of -10.57%. This prediction currently runs until 28.06.25. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
X4 Pharmaceuticals, Inc. | - |
iShares Core DAX® | 1.776% |
iShares Nasdaq 100 | -1.037% |
iShares Nikkei 225® | -0.335% |
iShares S&P 500 | 0.854% |
Comments by HC_Wainwright for this prediction
In the thread X4 Pharmaceuticals, Inc. diskutieren
X4 Pharmaceuticals, Inc. (NASDAQ: XFOR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Ratings data for XFOR provided by MarketBeat
Stopped prediction by HC_Wainwright for X4 Pharmaceuticals, Inc.
X4 Pharmaceuticals, Inc.
Start price
Target price
Perf. (%)
€1.04
30.04.24
30.04.24
€4.67
30.04.25
30.04.25
-48.07%
08.07.24
08.07.24
X4 Pharmaceuticals, Inc.
Start price
Target price
Perf. (%)
€1.35
22.03.24
22.03.24
€2.78
22.03.25
22.03.25
-60.19%
08.07.24
08.07.24
X4 Pharmaceuticals, Inc.
Start price
Target price
Perf. (%)
€0.95
11.08.23
11.08.23
€2.73
11.08.24
11.08.24
-43.12%
08.07.24
08.07.24